Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Vistagen Therapeutics (NASDAQ:VTGN) through any online brokerage.
There are no as such competitors for Vistagen Therapeutics.
Vistagen Therapeutics has a consensus price target of $6.45.
The stock price for Vistagen Therapeutics (NASDAQ: VTGN) is $0.63 last updated May 19, 2026 at 5:38 PM EDT.
There are no upcoming dividends for Vistagen Therapeutics.
Vistagen Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Vistagen Therapeutics.
Vistagen Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.